About
Membership and Partnership Overview
Features and Benefits of Membership
Staff
EBRI's Research Capabilities
EBRI Events and Publications
Features and Benefits of Research Center and Survey Partnerships
Members
About EBRI Research Center Partnerships
Member Portal
About EBRI Survey Partnerships
EBRI Upcoming Events
Features and Benefits of EBRI Partnerships
Sponsorship Opportunities
Public Policy Advisory Council
Diversity, Equity, and Inclusion Council
Retirement
Retirement Publications
401(k) Database
Retirement Confidence Survey
IRA Database
Retirement Security Research Center
Retirement Security Projection Model®
EBRI-Milken Institute 2024 Retirement Symposium
Ballpark E$timate
Public Retirement Research Lab
Health
Health Publications
EBRI/Greenwald Workplace Wellness Survey
EBRI/Greenwald Consumer Engagement in Health Care Survey
Center for Research on Health Benefits Innovation
HSA Database
FSA Database
Financial Wellbeing
Financial Wellbeing Publications
Financial Wellbeing Research Center
2023 Financial Wellbeing Symposium
Ballpark E$timate
Media
Resources
Policy Forums
Research Publications
EBRI Blog
Webinars
By the Numbers
Ballpark E$timate
Logout
Login
My Account
Welcome
Logout
Already A Member?
Access Member Portal
NOT A MEMBER YET?
SIGN UP TODAY
Home
/
Resources
/
Research Publications
/
EBRInteractive
/
HOPD-Infused Oncology Medicines Markup by MSAs and State
HOPD-Infused Oncology Medicines Markup by MSAs and State
For more information, please view our accompanying
Fast Fact
.
